Advisors Preferred LLC Acquires 2,276 Shares of The Clorox Company (NYSE:CLX)

Advisors Preferred LLC raised its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 86.2% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 4,916 shares of the company's stock after acquiring an additional 2,276 shares during the period. Advisors Preferred LLC's holdings in Clorox were worth $727,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in CLX. Redwood Park Advisors LLC acquired a new position in Clorox during the fourth quarter valued at approximately $26,000. Wood Tarver Financial Group LLC acquired a new position in shares of Clorox in the fourth quarter valued at approximately $31,000. GKV Capital Management Co. Inc. acquired a new position in shares of Clorox in the fourth quarter valued at approximately $32,000. Aster Capital Management DIFC Ltd acquired a new position in shares of Clorox in the fourth quarter valued at approximately $33,000. Finally, GW&K Investment Management LLC increased its holdings in Clorox by 239.1% during the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock worth $43,000 after purchasing an additional 208 shares in the last quarter. Institutional investors own 78.53% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on CLX shares. Wells Fargo & Company lowered their target price on Clorox from $142.00 to $135.00 and set an "equal weight" rating for the company in a report on Wednesday, July 9th. JPMorgan Chase & Co. lowered their target price on Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a report on Friday. Barclays lowered their target price on Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a report on Tuesday, July 15th. UBS Group lowered their target price on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a report on Thursday, July 17th. Finally, Evercore ISI set a $140.00 target price on shares of Clorox and gave the stock an "underperform" rating in a report on Tuesday, May 6th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $144.83.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber acquired 4,000 shares of the company's stock in a transaction dated Wednesday, May 7th. The shares were bought at an average cost of $136.57 per share, with a total value of $546,280.00. Following the completion of the transaction, the director directly owned 4,000 shares of the company's stock, valued at $546,280. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.57% of the stock is owned by insiders.

Clorox Stock Performance

NYSE:CLX traded down $0.62 during mid-day trading on Friday, hitting $130.80. The stock had a trading volume of 1,287,038 shares, compared to its average volume of 1,776,629. The Clorox Company has a twelve month low of $117.35 and a twelve month high of $171.37. The stock has a market cap of $16.12 billion, a price-to-earnings ratio of 23.48, a PEG ratio of 3.44 and a beta of 0.51. The company's 50 day simple moving average is $126.77 and its 200 day simple moving average is $140.15. The company has a debt-to-equity ratio of 13.07, a quick ratio of 0.44 and a current ratio of 0.74.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a net margin of 9.89% and a return on equity of 324.23%. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same quarter last year, the business posted $1.71 earnings per share. The company's revenue for the quarter was down 8.0% on a year-over-year basis. On average, equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.